Daily Monitor: Quality Chemical secures Shs133 billion loan to construct second plant
Released On May 23, 2025
QCIL's management is optimistic that this investment will not only increase production capacity for existing products but also enable the company to expand into new therapeutic area
The Chairman and Co-Founder of Qcil, Mr Emmanuel Katongole (left) and the chief executive officer of Stanbic Bank Uganda, Mr Mumba Kalifungwa (right) signing the credit facility documents.
Latest Media Releases
Qcil Marks 20 Years with Groundbreaking for New Factory and Launch of Paediatric HIV/AIDS Medicine
Qcil, the region’s leading pharmaceutical manufacturer, today marked a double milestone, celebrating 20 years of pharmaceutical excellence in Sub-Saharan Africa and breaking ground for a new state-of-the-art manufacturing facility at its Luzira Industrial Park campus in Kampala.
Business Focus Magazine: Qcil Beyond Healing
DEFINED BY ITS HOLISTIC APPROACH TO WELLNESS, AFRICAN PHARMACEUTICAL MANUFACTURER QCIL IS ENABLING MORE FULFILLING LIVES ACROSS THE CONTINENT.
CEO Magazine: How Qcil is Rewriting Africa's Healthcare Story from Dependency to Self-Reliance
CEO Magazine: How Qcil is Rewriting Africa's Healthcare Story from Dependency to Self-Reliance
CEO Magazine: Qcil's Profits jumps 22% to Shs.40.7 billion on steady sales and smart pricing
CEO Magazine: Qcil's Profits jumps 22% to Shs.40.7 billion on steady sales and smart pricing
Qcil POSTS RECORD PROFITS AND ANNOUNCES AMBITIOUS EXPANSION
“This expansion will enable us to do more for our patients, our people, and our economy.” said Mr. Katongole.